Where does Jasper Bos work?

Jasper Bos is General Partner at Forbion.

What does Jasper Bos invest in?

Jasper Bos invests in Biotech, Healthtech.

What check size does Jasper Bos write?

Jasper Bos typically writes checks of $100K – $5M.

What companies has Jasper Bos invested in?

Investments tracked here include Epitherapeutics, F-Star, Galecto, ObsEva, Prexton Therapeutics, Translate Bio.

Where did Jasper Bos go to school?

Jasper Bos studied at University of Groningen (PhD, pharmacy); Amsterdam Institute of Finance (Corporate Finance); University of Groningen (MSc, Pharmacy).

Jasper Bos

Investor

General Partner at Forbion

Naarden, Netherlands

Writes $100K – $5M checks · typically $1.5M

Find your path to Jasper

284 people in our graph share verified history with Jasper — schools, employers, funds. One of them is your warm intro.

Dominic SchmidtunlockedJasper: together at Anaveon (2022)

Jasper: together at Galecto, Inc.

×7Jasper: together at University of Groningen

Jasper: together at Anaveon

About

Jasper Bos is a General Partner at Forbion's Growth Fund. He previously served as Senior Vice President and Managing Director at M Ventures, Merck's venture arm, which he joined in 2009, where he led a team of investment professionals managing a €400 million fund across more than 50 biotech, life sciences tools, and tech companies. He holds a PhD in Pharmacy from the University of Groningen.

Invests in

BiotechHealthtech

Experience

Braveheart BioBoard Membercurrent2025 — presentSan Francisco Bay Area
CatalYm GmbHBoard Membercurrent2025 — present
CellCentricBoard Membercurrent2025 — present
Engrail TherapeuticsBoard Membercurrent2024 — presentSan Diego, California, United States
enGeneBoard Membercurrent2023 — presentBoston, Massachusetts, United States
ANAVEON AGBoard Membercurrent2022 — presentBasel, Switzerland
ForbionGeneral Partnercurrent2021 — presentNaarden, North Holland, Netherlands
ForbionForbion European Acquisition Corporation (NASDAQ: FRBN) Chief Executive Officer2021 — 2023Amsterdam Area
M VenturesSenior Vice President & Managing Director2019 — 2021Amsterdam
M VenturesVice President, Head of Healthcare Fund M Ventures2016 — 2019Switzerland
Metabomed Ltd.Member of the Board of Directors2016 — 2021Yavne
Galecto, Inc.Member of the Board of Directors2012 — 2019
Calypso biotech SAChairman Of The Board Of Directors2013 — 2019Geneva, Geneva, Switzerland
Prexton Therapeutics SABoard Member2012 — 2018
Neviah GenomicsBoard Member2012 — 2016Tel Aviv, Israel
Merck SeronoSenior Director MS Ventures2014 — 2016
Merck SeronoDirector Merck Serono Ventures2011 — 2014
Merck SeronoAssociate Director Merck Serono Ventures2009 — 2011
ObsEva SABoard Member2013 — 2016Geneva, Geneva, Switzerland
Asceneuron SABoard Member2012 — 2015Lausanne, Vaud, Switzerland
EpiTherapeutics ApSBoard Member2010 — 2015
The Investment Fund for Health in AfricaAssociate2007 — 2009
PharmAccess FoundationHead Product Development /business development2004 — 2007
Netherlands Vaccine InstituteHealth Economics and Strategy Analyst2001 — 2004
University of GroningenPhD research fellow1999 — 2001
National Institute for Public Health and the EnvironmentHealth Economics Researcher1998 — 1999

Skills & more

Strategy51Biotechnology49Drug Discovery16Technology Transfer15Lifesciences23Health Economics30Oncology12Clinical Trials7Molecular Biology5Drug Development52Clinical Development17R&D5

+12 more

Regulatory AffairsBiopharmaceuticalsVaccinesGCPMarket AccessNeuroscienceCompetitive IntelligenceCommercializationBiochemistryPharmaceutical IndustryMedical WritingProtein Chemistry

From Jasper's professional profile.

Investments

Investor

EpitherapeuticsF-StarGalectoObsEvaPrexton TherapeuticsTranslate Bio

Per the firm's website.

Colleagues at Forbion

Alexander Hoffmann

General Partner at Forbion

Alice Vickers

Advisor at Forbion

Antoine Boulanger Piette

Operating Partner at Forbion

Dirk Kersten

Managing Partner at Forbion

Dmitrij Hristodorov

General Partner at Forbion

Geert-Jan Mulder

Managing Partner at Forbion

Frequently asked questions

Who is Jasper Bos?: Jasper Bos is a General Partner at Forbion's Growth Fund. He previously served as Senior Vice President and Managing Director at M Ventures, Merck's venture arm, which he joined in 2009, where he led a team of investment professionals managing a €400 million fund across more than 50 biotech, life sciences tools, and tech companies. He holds a PhD in Pharmacy from the University of Groningen.
Where does Jasper Bos work?: Jasper Bos is General Partner at Forbion.
What does Jasper Bos invest in?: Jasper Bos invests in Biotech, Healthtech.
What check size does Jasper Bos write?: Jasper Bos typically writes checks of $100K – $5M.
What companies has Jasper Bos invested in?: Investments tracked here include Epitherapeutics, F-Star, Galecto, ObsEva, Prexton Therapeutics, Translate Bio.
Where did Jasper Bos go to school?: Jasper Bos studied at University of Groningen (PhD, pharmacy); Amsterdam Institute of Finance (Corporate Finance); University of Groningen (MSc, Pharmacy).

Same school

Also attended University of Groningen183

Ragnar JongenInvestor at DN Capital Jelle Van de PutteFund Administrator at Capricorn Venture Partners Laura LentzExecutive Assistant at Castle Island Ventures Christophe de MontillePartner at Beyond Capital Ventures Peter HaasjesHead of Investments at Noaber Marlene van LooProgramma manager at Noaber

+ 177 more

Also attended Amsterdam Institute of Finance12

Nesbit WestAdvisor - Fund Compliance at Keen Venture Partners Hugo de BruinGeneral Partner at Gilde Healthcare Lex RoukensManaging Partner at Move Energy Riemer SminkManaging Partner at FORWARD.one Hans van HouwelingenManaging Partner at Urban Impact Ventures Frank HeesselsSenior Technology Manager, Europe at SABIC Ventures

+ 6 more

Shared employers

Also worked at CatalYm GmbH7

Marianne UtengManaging Director at Novartis Venture Fund Daniela CoutoGeneral Partner at BioGeneration Ventures Marc LohrmannManaging Partner at Vesalius Biocapital III Partners SàRL Pascal TouchonOperating Partner at Jeito Capital HelmsManaging Director & Chief Financial Officer at Longitude Capital Jon EdwardsGeneral Partner at Forbion

+ 1 more

Also worked at enGene5

Gerry BrunkManaging Director at Lumira Ventures Sharon TanExecutive in Residence at Iaso Ventures Marco BoorsmaGeneral Partner at Forbion Wouter JoustraGeneral Partner at Forbion Bill GrossmanCo-founder, Strategic Advisor at Oncko

Also worked at M Ventures34

Roel BulthuisInvestor at Syncona Arturo UrriosPartner at Ysios Capital Therese LiechtensteinPartner at 4BIO Capital Dave RosenbergInvestor at ACVC Partners Dr. Nadine GeiserPrincipal at World Fund Toby LovettGeneral Counsel at World Fund

+ 28 more

Also worked at University of Groningen23

Ragnar JongenInvestor at DN Capital Saskia HoebéePartner at Five Seasons Ventures Xander WolfkampSenior Investment Manager at NPM Capital N.V.Ashley KlapwijkInvestment Manager at Eneco Ventures Boudewijn HulstInvestmentmanager IT NOM at NV NOM David VroomInvestmentmanager NOM at NV NOM

+ 17 more